Novo Nordisk hits $500bn market value as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year

Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the weight loss-aiding drugmaker has hit its latest milestone as bumper earnings helped propel it to a record valuation. On the back of the earnings, the group behind Ozempic and Wegovy…#novonordisk #ozempicandwegovy #wegovy #novo #glp1 #ozempicand #bernardarnaults #denmark #danskebank #danish
Source: Reuters: Health - Category: Consumer Health News Source Type: news